HSBC Holdings’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.8M Sell
189,237
-53,798
-22% -$6.76M 0.01% 596
2025
Q1
$26.9M Buy
243,035
+30,681
+14% +$3.39M 0.02% 574
2024
Q4
$29M Sell
212,354
-10,904
-5% -$1.49M 0.02% 576
2024
Q3
$25.7M Buy
223,258
+110,185
+97% +$12.7M 0.01% 597
2024
Q2
$15.6M Sell
113,073
-26,793
-19% -$3.69M 0.01% 669
2024
Q1
$19.3M Buy
139,866
+35,910
+35% +$4.95M 0.01% 655
2023
Q4
$13.7M Buy
103,956
+25,975
+33% +$3.43M 0.01% 693
2023
Q3
$8.78M Buy
77,981
+1,012
+1% +$114K 0.01% 745
2023
Q2
$7.26M Sell
76,969
-37,946
-33% -$3.58M 0.01% 797
2023
Q1
$11.6M Buy
114,915
+36,616
+47% +$3.7M 0.01% 692
2022
Q4
$9.35M Buy
78,299
+10,291
+15% +$1.23M 0.01% 832
2022
Q3
$7.22M Buy
68,008
+9,334
+16% +$991K 0.01% 873
2022
Q2
$5.72M Buy
58,674
+518
+0.9% +$50.5K 0.01% 971
2022
Q1
$5.45M Buy
58,156
+4,781
+9% +$448K 0.01% 982
2021
Q4
$4.55M Buy
53,375
+8,975
+20% +$765K ﹤0.01% 1036
2021
Q3
$4.26M Buy
44,400
+13,817
+45% +$1.32M ﹤0.01% 957
2021
Q2
$2.99M Buy
30,583
+20,357
+199% +$1.99M ﹤0.01% 1026
2021
Q1
$993K Sell
10,226
-6,190
-38% -$601K ﹤0.01% 1307
2020
Q4
$1.58M Buy
16,416
+1,379
+9% +$133K ﹤0.01% 1110
2020
Q3
$1.45M Sell
15,037
-3,540
-19% -$342K ﹤0.01% 1063
2020
Q2
$2.27M Buy
18,577
+11,975
+181% +$1.46M ﹤0.01% 890
2020
Q1
$572K Sell
6,602
-8,090
-55% -$701K ﹤0.01% 1338
2019
Q4
$1.59M Sell
14,692
-4,039
-22% -$436K ﹤0.01% 1150
2019
Q3
$1.69M Buy
18,731
+5,250
+39% +$473K ﹤0.01% 1177
2019
Q2
$1.14M Buy
13,481
+3,486
+35% +$294K ﹤0.01% 1212
2019
Q1
$880K Sell
9,995
-137,106
-93% -$12.1M ﹤0.01% 1391
2018
Q4
$10.5M Buy
147,101
+131,592
+848% +$9.4M 0.02% 558
2018
Q3
$1.9M Buy
+15,509
New +$1.9M ﹤0.01% 1058
2018
Q1
Sell
-5,765
Closed -$447K 1986
2017
Q4
$447K Buy
+5,765
New +$447K ﹤0.01% 1458